Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with Holos Life Sciences Pte. Ltd. to develop non-invasive epigenetic biomarkers associated with sports-related concussions; and Casa Sollievo della Sofferenza to identify EpiSwitch biomarkers for the blood-based diagnosis of Autism Spectrum Disorder. The company was founded in 2007 and is headquartered in Oxford, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1865-518910
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£1.19 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Oxford Biodynamics (LON:OBD) Frequently Asked Questions
What is Oxford Biodynamics' stock symbol?
Oxford Biodynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."
How were Oxford Biodynamics' earnings last quarter?
Has Oxford Biodynamics been receiving favorable news coverage?
Press coverage about OBD stock has trended somewhat negative recently, according to InfoTrie. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Oxford Biodynamics earned a news sentiment score of -1.1 on InfoTrie's scale. They also gave media coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
Who are some of Oxford Biodynamics' key competitors?
Some companies that are related to Oxford Biodynamics include Theratechnologies (TH), Biotest (BIO), Polynovo (PNV), Senesco Technologies (ELOX), Oxford BioMedica (OXB), Starpharma (SPL), Neptune Wellness Solutions (NEPT), IMV (IMV), Monash IVF Group (MVF), Enochian Biosciences (ENOB), Kodiak Sciences (KOD), Horizon Discovery Group (HZD), Emblem (EMC), BELLUS Health (BLU) and BioTime (BTX).
What other stocks do shareholders of Oxford Biodynamics own?
Who are Oxford Biodynamics' key executives?
Oxford Biodynamics' management team includes the folowing people:
- Mr. Christian Gurth Hoyer Millar, CEO & Director (Age 60)
- Mr. Paul Leslie Stockdale, CFO & Director (Age 44)
- Dr. Alexandre Akoulitchev, Chief Scientific Officer & Director (Age 57)
- Dr. Aroul Ramadass Ph.D.(CANTAB), PDF (OXON), FCPS, FRAS, Chief Technology Officer
- Mr. Martin Reeves, Sr. VP of Commercial Devel.
How do I buy shares of Oxford Biodynamics?
Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Oxford Biodynamics' stock price today?
One share of OBD stock can currently be purchased for approximately GBX 150.
How big of a company is Oxford Biodynamics?
Oxford Biodynamics has a market capitalization of £138.84 million and generates £1.19 million in revenue each year.
What is Oxford Biodynamics' official website?
How can I contact Oxford Biodynamics?
Oxford Biodynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The biotechnology company can be reached via phone at +44-1865-518910.
MarketBeat Community Rating for Oxford Biodynamics (LON OBD)
MarketBeat's community ratings are surveys of what our community members think about Oxford Biodynamics and other stocks. Vote "Outperform" if you believe OBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
